Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (239) 239
male (204) 204
female (189) 189
middle aged (185) 185
cardiac & cardiovascular systems (172) 172
index medicus (151) 151
aged (133) 133
treatment outcome (81) 81
percutaneous coronary intervention (77) 77
stents (73) 73
cardiology (67) 67
cardiovascular (64) 64
heart attacks (60) 60
adult (57) 57
myocardial infarction (57) 57
time factors (54) 54
myocardial infarction - therapy (53) 53
angioplasty (51) 51
abridged index medicus (50) 50
electrocardiography (50) 50
care and treatment (47) 47
drug-eluting stents (47) 47
follow-up studies (47) 47
coronary angiography (40) 40
stent (40) 40
thrombosis (40) 40
heart attack (39) 39
risk factors (39) 39
mortality (37) 37
follow-up (34) 34
cardiac patients (33) 33
internal medicine (33) 33
myocardial infarction - mortality (33) 33
prognosis (33) 33
radiology, nuclear medicine & medical imaging (33) 33
cardiology and cardiovascular medicine (32) 32
coronary vessels (32) 32
acute myocardial-infarction (29) 29
primary angioplasty (29) 29
angioplasty, balloon, coronary (28) 28
sirolimus - administration & dosage (28) 28
myocardial infarction - diagnosis (26) 26
predictive value of tests (26) 26
prospective studies (26) 26
implantation (25) 25
risk (25) 25
clinical trials (24) 24
transluminal angioplasty (24) 24
bare-metal stents (23) 23
revascularization (23) 23
analysis (22) 22
aged, 80 and over (21) 21
cardiovascular disease (21) 21
drug-eluting stent (21) 21
patient outcomes (21) 21
angina pectoris (20) 20
medicine & public health (20) 20
medicine, general & internal (20) 20
metaanalysis (20) 20
myocardial infarction - physiopathology (20) 20
outcomes (20) 20
peripheral vascular disease (20) 20
heart (19) 19
randomized controlled trials as topic (19) 19
reproducibility of results (19) 19
risk assessment (19) 19
angiography (18) 18
coronary artery disease - diagnostic imaging (18) 18
diabetes (18) 18
radionuclide imaging (18) 18
recurrence (18) 18
restenosis (18) 18
sirolimus - analogs & derivatives (18) 18
st-segment elevation myocardial infarction (18) 18
ischemia (17) 17
medical research (17) 17
patients (17) 17
percutaneous coronary intervention - methods (17) 17
retrospective studies (17) 17
severity of illness index (17) 17
artery-disease (16) 16
clinical outcomes (16) 16
coronary artery disease (16) 16
drug-eluting stents - adverse effects (16) 16
heart - diagnostic imaging (16) 16
intervention (16) 16
paclitaxel (16) 16
balloon angioplasty (15) 15
cardiovascular diseases (15) 15
denmark (15) 15
denmark - epidemiology (15) 15
disease (15) 15
heart failure (15) 15
intravascular ultrasound (15) 15
kaplan-meier estimate (15) 15
myocardial infarction - surgery (15) 15
proportional hazards models (15) 15
stent thrombosis (15) 15
therapy (15) 15
trial (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Spotlight: Henning Kelbaek, MD, DMedSci
by Taylor, J and Kelbaek, H
CIRCULATION, ISSN 0009-7322, 03/2009, Volume 119, Issue 9, pp. F49 - F51
CARDIAC & CARDIOVASCULAR SYSTEMS | DRUG ELUTION | CORONARY | DEDICATION TRIAL | PERIPHERAL VASCULAR DISEASE | STENTS | HEMATOLOGY | DISTAL PROTECTION | ELEVATION MYOCARDIAL-INFARCTION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
by Engstrøm, Thomas, MD and Kelbæk, Henning, Dr and Helqvist, Steffen, MD and Høfsten, Dan Eik, MD and Kløvgaard, Lene, RN and Holmvang, Lene, MD and Jørgensen, Erik, MD and Pedersen, Frants, MD and Saunamäki, Kari, MD and Clemmensen, Peter, Prof and De Backer, Ole, MD and Ravkilde, Jan, MD and Tilsted, Hans-Henrik, MD and Villadsen, Anton Boel, MD and Aarøe, Jens, MD and Jensen, Svend Eggert, MD and Raungaard, Bent, MD and Køber, Lars, Prof and DANAMI-3-PRIMULTI Investigators and DANAMI-3—PRIMULTI Investigators
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9994, pp. 665 - 671
Summary Background Patients with acute ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease have a worse prognosis compared with... 
Internal Medicine | FRACTIONAL FLOW RESERVE | MORTALITY | FOLLOW | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | VESSEL | IMPACT | MANAGEMENT | TIME | OUTCOMES | Myocardial Infarction - surgery | Reoperation | Postoperative Complications - etiology | Humans | Middle Aged | Myocardial Revascularization - methods | Male | Treatment Outcome | Fractional Flow Reserve, Myocardial - physiology | Coronary Stenosis - surgery | Percutaneous Coronary Intervention - methods | Coronary Stenosis - physiopathology | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Myocardial Infarction - physiopathology | Aged | Care and treatment | Surgery | Heart attack | Heart attacks | Coronary vessels | Medical treatment | Cardiovascular disease | Cardiology | Stents | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial
by Maeng, Michael, Dr and Tilsted, Hans Henrik, MD and Jensen, Lisette Okkels, MD and Krusell, Lars Romer, MD and Kaltoft, Anne, MD and Kelbæk, Henning, MD and Villadsen, Anton B, MD and Ravkilde, Jan, MD and Hansen, Knud Nørregaard, MD and Christiansen, Evald Høj, MD and Aarøe, Jens, MD and Jensen, Jan Skov, Prof and Kristensen, Steen Dalby, Prof and Bøtker, Hans Erik, Prof and Thuesen, Leif, MD and Madsen, Morten, MSc and Thayssen, Per, MD and Sørensen, Henrik Toft, Prof and Lassen, Jens Flensted, MD
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9934, pp. 2047 - 2056
Summary Background In head-to-head comparisons of coronary drug-eluting stents, the primary endpoint is traditionally assessed after 9–12 months. However, the... 
Internal Medicine | ANGIOGRAPHIC OUTCOMES | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | SCANDINAVIAN ORGANIZATION | SAFETY | BARE-METAL STENTS | NON-INFERIORITY TRIAL | FOLLOW-UP | INTERVENTION | ENDEAVOR-III | ARTERY-DISEASE | Single-Blind Method | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Cytostatic Agents - administration & dosage | Male | Treatment Outcome | Cytostatic Agents - therapeutic use | Drug-Eluting Stents - adverse effects | Cytostatic Agents - adverse effects | Sirolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Coronary Thrombosis - etiology | Myocardial Infarction - etiology | Research Design | Sirolimus - adverse effects | Complications and side effects | Usage | Drug-eluting stents | Zotarolimus | Dosage and administration | Research | Health aspects | Comparative analysis | Stent (Surgery) | Transluminal angioplasty | Heart | Cardiology | Studies | Heart attacks | Angina pectoris | Stents | Coronary vessels | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial
by Kelbæk, Henning, Dr and Høfsten, Dan Eik, MD and Køber, Lars, Prof and Helqvist, Steffen, MD and Kløvgaard, Lene, RN and Holmvang, Lene, MD and Jørgensen, Erik, MD and Pedersen, Frants, MD and Saunamäki, Kari, MD and De Backer, Ole, MD and Bang, Lia E, MD and Kofoed, Klaus F, MD and Lønborg, Jacob, MD and Ahtarovski, Kiril, MD and Vejlstrup, Niels, MD and Bøtker, Hans E, Prof and Terkelsen, Christian J, MD and Christiansen, Evald H, MD and Ravkilde, Jan, MD and Tilsted, Hans-Henrik, MD and Villadsen, Anton B, MD and Aarøe, Jens, MD and Jensen, Svend E, MD and Raungaard, Bent, MD and Jensen, Lisette O, MD and Clemmensen, Peter, Prof and Grande, Peer, MD and Madsen, Jan K, MD and Torp-Pedersen, Christian, Prof and Engstrøm, Thomas, MD
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10034, pp. 2199 - 2206
Summary Background Despite successful treatment of the culprit artery lesion by primary percutaneous coronary intervention (PCI) with stent implantation,... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | PROTECTION | THROMBUS ASPIRATION | THROMBECTOMY | NO-REFLOW PHENOMENON | BALLOON ANGIOPLASTY | IMMEDIATE | DISTAL EMBOLIZATION | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Drug-Eluting Stents | Humans | Middle Aged | Male | Myocardial Infarction - therapy | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Aged, 80 and over | Adult | Female | Aged | Adrenergic beta-Antagonists - administration & dosage | Transluminal angioplasty | Care and treatment | Cardiology | Cardiac patients | Heart attack | Stent (Surgery) | Analysis | Clinical trials | Studies | Heart failure | Heart attacks | Transplants & implants | Coronary vessels | Stents | Clinical outcomes | Blood clots
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text System Delay and Timing of Intervention in Acute Myocardial Infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] Trial)
by Nielsen, Peter H., MD and Terkelsen, Christian J., MD, PhD and Nielsen, Torsten T., MD, DMSc and Thuesen, Leif, MD, DMSc and Krusell, Lars R., MD and Thayssen, Per, MD, DMSc and Kelbæk, Henning, MD, DMSc and Abildgaard, Ulrik, MD and Villadsen, Anton B., MD and Andersen, Henning R., MD, DMSc and Maeng, Michael, MD, PhD and Danami-2 Investigators
American Journal of Cardiology, The, ISSN 0002-9149, 2011, Volume 108, Issue 6, pp. 776 - 781
The interval from the first alert of the healthcare system to the initiation of reperfusion therapy (system delay) is associated with mortality in patients... 
Cardiovascular | MORTALITY | PERCUTANEOUS CORONARY INTERVENTION | TO-BALLOON TIME | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | REPERFUSION THERAPY | ST-SEGMENT ELEVATION | FIBRINOLYTIC THERAPY | PRIMARY ANGIOPLASTY | Myocardial Infarction - mortality | Prognosis | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Treatment Outcome | Chi-Square Distribution | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Myocardial Reperfusion | Time Factors | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Denmark - epidemiology | Female | Myocardial Infarction - physiopathology | Aged | Cardiac patients | Heart attack
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
by Rasmussen, Klaus, MD and Maeng, Michael, MD and Kaltoft, Anne, MD and Thayssen, Per, MD and Kelbæk, Henning, MD and Tilsted, Hans Henrik, MD and Abildgaard, Ulrik, MD and Christiansen, Evald Høj, MD and Engstrøm, Thomas, MD and Krusell, Lars Romer, MD and Ravkilde, Jan, MD and Hansen, Peter Riis, MD and Hansen, Knud Nørregaard, MD and Abildstrøm, Steen Zabell, MD and Aarøe, Jens, MD and Jensen, Jan Skov, MD and Kristensen, Steen Dalby, MD and Bøtker, Hans Erik, Prof and Madsen, Morten, MSc and Johnsen, Søren Paaske, MD and Jensen, Lisette Okkels, MD and Sørensen, Henrik Toft, Prof and Thuesen, Leif, MD and Lassen, Jens Flensted, Dr and SORT OUT III Study Grp and SORT OUT III study group
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9720, pp. 1090 - 1099
Summary Background In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing the risk of stent... 
Internal Medicine | DRUG | MEDICINE, GENERAL & INTERNAL | THROMBOSIS | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | ARTERY LESIONS | DISEASE | ACUTE MYOCARDIAL-INFARCTION | FOLLOW-UP | ENDEAVOR | OUTCOMES | Single-Blind Method | Sirolimus - analogs & derivatives | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Angioplasty, Balloon, Coronary | Drug-Eluting Stents - adverse effects | Retreatment | Thrombosis - etiology | Coronary Disease - therapy | Female | Aged | Myocardial Infarction - etiology | Sirolimus - adverse effects | Care and treatment | Patient outcomes | Dosage and administration | Coronary heart disease | Health aspects | Immunosuppressive agents | Stent (Surgery) | Studies | Intervention | Heart attacks | Medical imaging | Angioplasty | Cardiovascular disease | Clinical medicine | Acute coronary syndromes | Stents | Blood clots
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: A Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy
by Fosbøl, Emil Loldrup and Thune, Jens Jakob, MD and Kelbæk, Henning, MD, DSc and Andersen, Henning Rud, MD, DSc and Saunamäki, Kari, MD, DSc and Nielsen, Torsten Toftegaard, MD, DSc and Mortensen, Leif Spange, MSc, DSc and Køber, Lars, MD, DSc and DANAMI 2 Investigators and DANAMI-2 Investigators
American Heart Journal, ISSN 0002-8703, 2008, Volume 156, Issue 2, pp. 391 - 396
Background Primary angioplasty in patients with acute ST-elevation myocardial infarction has been shown to be superior to fibrinolysis. Whether elderly... 
Cardiovascular | MORTALITY | POOLED ANALYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOLYTIC THERAPY | ELDERLY-PATIENTS | INTERVENTION | Myocardial Infarction - mortality | Age Factors | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Male | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Myocardial Infarction - drug therapy | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Transluminal angioplasty | Comparative analysis | Cardiology | Heart attack | Cardiovascular agents | Confidence intervals | Variables | Survival analysis | Stroke | Heart attacks | Angioplasty | Mortality | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI
by Pedersen, Frants, MD, PhD and Butrymovich, Vitalij, MD and Kelbæk, Henning, MD, DMSc and Wachtell, Kristian, MD, PhD and Helqvist, Steffen, MD, DMSc and Kastrup, Jens, MD, DMSc and Holmvang, Lene, MD, DMSc and Clemmensen, Peter, MD, DMSc and Engstrøm, Thomas, MD, PhD, DMSc and Grande, Peer, MD, DMSc and Saunamäki, Kari, MD, DMSc and Jørgensen, Erik, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 20, pp. 2101 - 2108
Abstract Background Short-term mortality has been studied thoroughly in patients undergoing primary percutaneous coronary intervention (PCI), whereas long-term... 
Cardiovascular | Internal Medicine | percutaneous coronary intervention | cause of death | follow-up study | acute myocardial infarction | Follow-up study | Percutaneous coronary intervention | Acute myocardial infarction | Cause of death | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOGENIC-SHOCK | DEDICATION TRIAL | ACUTE MYOCARDIAL-INFARCTION | VENTRICULAR ASSIST DEVICE | CARDIAC REHABILITATION | THROMBOLYTIC THERAPY | DISTAL PROTECTION | PRIMARY ANGIOPLASTY | FIBRINOLYTIC THERAPY | Myocardial Infarction - surgery | Percutaneous Coronary Intervention - trends | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Risk Factors | Male | Time Factors | Cause of Death - trends | Female | Registries | Aged | Transluminal angioplasty | Care and treatment | Cardiac patients | Mortality | Hypertension | Heart failure | Cardiac arrhythmia | Pneumonia | Heart attacks | Multiple organ dysfunction syndrome | Emigration | Clinical trials | Cardiovascular disease | Regression analysis | Multivariate analysis | Abdomen | Confidence intervals | Body mass index | Registration | Brain damage | Diabetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
by Kastrati, Adnan and Mehilli, Julinda and Pache, Jürgen and Kaiser, Christoph and Valgimigli, Marco and Kelbæk, Henning and Menichelli, Maurizio and Sabaté, Manel and Suttorp, Maarten J and Baumgart, Dietrich and Seyfarth, Melchior and Pfisterer, Matthias E and Schömig, Albert
New England Journal of Medicine, ISSN 0028-4793, 03/2007, Volume 356, Issue 10, pp. 1030 - 1039
BACKGROUND: The long-term effects of treatment with sirolimus-eluting stents, as compared with bare-metal stents, have not been established. METHODS: We... 
MEDICINE, GENERAL & INTERNAL | SYSTEMATIC REVIEWS | UNCOATED STENTS | METAANALYSIS | ACUTE MYOCARDIAL-INFARCTION | SMALL CORONARY-ARTERIES | DOUBLE-BLIND | STANDARD STENT | FOLLOW-UP | INDIVIDUAL PATIENT DATA | RANDOMIZED CLINICAL-TRIALS | Myocardial Infarction - epidemiology | Coronary Thrombosis - epidemiology | Follow-Up Studies | Humans | Risk | Prosthesis Design | Coronary Disease - mortality | Coronary Restenosis - therapy | Angioplasty, Balloon, Coronary | Drug Delivery Systems | Randomized Controlled Trials as Topic | Regression Analysis | Sirolimus - administration & dosage | Coronary Restenosis - epidemiology | Prosthesis Failure | Coronary Disease - therapy | Survival Analysis | Coronary Thrombosis - etiology | Stents - adverse effects | Myocardial Infarction - etiology | Immunosuppressive Agents - administration & dosage | Usage | Care and treatment | Analysis | Thrombosis | Stent (Surgery) | Blood clot | Heart attack | Risk factors | Clinical trials | Cardiovascular disease | Heart attacks | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice: The SORT OUT II Randomized Trial
by Galløe, Anders M and Thuesen, Leif and Kelbæk, Henning and Thayssen, Per and Rasmussen, Klaus and Hansen, Peter R and Bligaard, Niels and Saunamäki, Kari and Junker, Anders and Aarøe, Jens and Abildgaard, Ulrik and Ravkilde, Jan and Engstrøm, Thomas and Jensen, Jan S and Andersen, Henning R and Bøtker, Hans E and Galatius, Søren and Kristensen, Steen D and Madsen, Jan K and Krusell, Lars R and Abildstrøm, Steen Z and Stephansen, Ghita B and Lassen, Jens F and SORT OUT II Investigators, for the and SORT OUT II Investigators
JAMA, ISSN 0098-7484, 01/2008, Volume 299, Issue 4, pp. 409 - 416
CONTEXT Approval of drug-eluting coronary stents was based on results of relatively small trials of selected patients; however, in routine practice, stents are... 
MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | METAANALYSIS | RESTENOSIS | INTRAVASCULAR ULTRASOUND | OUTCOMES | INTERVENTION | CORONARY-ARTERY-DISEASE | LESIONS | Drug-Eluting Stents | Humans | Middle Aged | Male | Treatment Outcome | Angina Pectoris - therapy | Thrombosis | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Sirolimus - administration & dosage | Female | Aged | Paclitaxel - administration & dosage | Care and treatment | Research | Comparative analysis | Cardiovascular instruments, Implanted | Cardiac patients | Paclitaxel | Drugs | Clinical trials | Clinical medicine | Angioplasty | Stents | Medical treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
by Serruys, Patrick W and Silber, Sigmund and Garg, Scot and van Geuns, Robert Jan and Richardt, Gert and Buszman, Pawel E and Kelbæk, Henning and van Boven, Adrianus Johannes and Hofma, Sjoerd H and Linke, Axel and Klauss, Volker and Wijns, William and Macaya, Carlos and Garot, Philippe and DiMario, Carlo and Manoharan, Ganesh and Kornowski, Ran and Ischinger, Thomas and Bartorelli, Antonio and Ronden, Jacintha and Bressers, Marco and Gobbens, Pierre and Negoita, Manuela and van Leeuwen, Frank and Windecker, Stephan
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 2, pp. 136 - 146
This study compared two new-generation drug-eluting coronary stents that release zotarolimus or everolimus. Clinical and angiographic outcomes were similar... 
SYSTEM | MEDICINE, GENERAL & INTERNAL | RANDOMIZED-TRIAL | THERAPY | THROMBOSIS | INTERVENTION | Myocardial Infarction - epidemiology | Sirolimus - analogs & derivatives | Humans | Middle Aged | Coronary Restenosis | Kaplan-Meier Estimate | Male | Prosthesis Design | Coronary Disease - mortality | Drug-Eluting Stents - adverse effects | Coronary Angiography | Myocardial Infarction - therapy | Retreatment | Sirolimus - administration & dosage | Treatment Failure | Coronary Disease - therapy | Intention to Treat Analysis | Female | Aged | Everolimus | Health aspects | Patient outcomes | Coronary stenosis | Cardiovascular disease | Heart attacks | Acute coronary syndromes | Stents | Blood clots
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): A serial intravascular ultrasonography study
by Räber, Lorenz and Taniwaki, Masanori and Zaugg, Serge and Kelbãk, Henning and Roffi, Marco and Holmvang, Lene and Noble, Stephane and Pedrazzini, Giovanni and Moschovitis, Aris and Lüscher, Thomas F and Matter, Christian M and Serruys, Patrick W and Jüni, Peter and Garcia-Garcia, Hector M and Windecker, Stephan and IBIS 4 Integrated Biomarkers & Ima and IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416)
European Heart Journal, ISSN 0195-668X, 02/2015, Volume 36, Issue 8, pp. 490 - 500
Aim The effect of long-term high-intensity statin therapy on coronary atherosclerosis among patients with acute ST-segment elevation myocardial infarction... 
Intravascular Ultrasound | ST-elevation myocardial infarction | Statin | Radiofrequency | Atherosclerosis | CARDIAC & CARDIOVASCULAR SYSTEMS | RUPTURED PLAQUES | EVENTS | METAANALYSIS | EFFICACY | BARE-METAL STENTS | AMI TRIAL | ULTRASOUND | ACUTE MYOCARDIAL-INFARCTION | ROSUVASTATIN | PROGRESSION | Myocardial Infarction - surgery | Plaque, Atherosclerotic - diagnostic imaging | Prospective Studies | Rosuvastatin Calcium - therapeutic use | Cholesterol, HDL - metabolism | Humans | Middle Aged | Ultrasonography, Interventional | Male | Treatment Outcome | Myocardial Infarction - diagnostic imaging | Coronary Artery Disease - drug therapy | Cardiovascular Agents - therapeutic use | Coronary Artery Disease - diagnostic imaging | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Myocardial Infarction - pathology | Coronary Artery Disease - pathology | Cholesterol, LDL - metabolism | Female | Plaque, Atherosclerotic - drug therapy | Plaque, Atherosclerotic - pathology | Percutaneous Coronary Intervention
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents
by Galløe, Anders M., MD, PhD and Kelbæk, Henning, MD, DMSc and Thuesen, Leif, MD, DMSc and Hansen, Henrik S., MD, DMSc and Ravkilde, Jan, MD, DMSc and Hansen, Peter R., MD, PhD, DMSc and Christiansen, Evald H., MD, DMSc and Abildgaard, Ulrik, MD, DMSc and Stephansen, Ghita, RN and Lassen, Jens F., MD, PhD and Engstrøm, Thomas, MD, PhD, DMSc and Jensen, Jan Skov, MD, PhD, DMSc and Jeppesen, Jørgen L., MD, DMSc and Bligaard, Niels, MD and SORT OUT II Investigators
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 6, pp. 616 - 624
Abstract Background First-generation drug-eluting coronary stents (DES) were introduced in 2003 to 2004, and their use resulted in a considerable reduction in... 
Cardiovascular | Internal Medicine | coronary disease | stent thrombosis | survival | angioplasty | DRUG | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EFFICACY | THROMBOSIS | SAFETY | BARE-METAL STENTS | FOLLOW-UP | MECHANISMS | IMPLANTATION | Coronary Artery Disease - surgery | Drug-Eluting Stents | Immunosuppressive Agents | Follow-Up Studies | Sirolimus | Humans | Middle Aged | Male | Treatment Outcome | Coronary Restenosis - epidemiology | Time Factors | Paclitaxel | Female | Aged | Graft Occlusion, Vascular - epidemiology | Rapamycin | Stent (Surgery) | Coronary heart disease | Patient outcomes | Heart attacks | Emigration | Values | Cardiovascular disease | Angina pectoris | Thrombosis | Patients | Clinical outcomes | Studies | Confidence intervals | Coronary vessels | Electrocardiography | Acute coronary syndromes | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights